Skip to content

Online nurse-assisted eye-screening in home healthcare; implementation study and economic evaluation, from an individual, healthcare and socio-political perspective [iSCREEN-study]

Online nurse-assisted eye-screening in home healthcare; implementation study and economic evaluation, from an individual, healthcare and socio-political perspective [iSCREEN-study] - iSCREEN-study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON54100
Enrollment
220
Registered
2022-12-20
Start date
2023-03-23
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual impairment

Interventions

On top of usual care, nurse-assisted eye-screening takes place with the Easee app, which is implemented on the tablet or laptop of the community nurse. Participants will be referred if necessary and

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
65 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients receive home healthcare for health problems - 65 years or older (query) - Understanding of the Dutch language (telephone assessment) - Cognitive ability to participate in research (telephone assessment: six-item Mini Mental State Examination score >3)

Exclusion criteria

Exclusion criteria: - Very serious health condition of the patient (query: e.g. terminal illness, receiving palliative home care) - Cognitively unable to participate in research (query: e.g. late stage Alzheimer's, Parkinson's) - Having received an optometric or ophthalmic consultation within the last 6 months (query and telephone assessment)

Design outcomes

Primary

MeasureTime frame
Primary outcome is incidence in clinically relevant progress of 10 letters (2 lines, exceeding measurement error) or more on the Colenbrander-1M visual acuity chart between baseline and 12 months follow-up. Measurements are performed in participants' homes by research assistants from Amsterdam UMC at baseline, after 6 and after 12 months.

Secondary

MeasureTime frame
• Vision-related measures: - Average visual acuity change in letters per participant and eye between baseline and 12 months follow-up, including stenopeic visual acuity. - Number of participants and eyes with baseline visual impairment (visual acuity 8/24 or lower) with clinically relevant progress of 10 letters or more. - Optometric status 12 months after baseline. This measurement will be used for diagnostic purposes indicating whether we may have missed (latent) pathology in both groups, but also to make sure that all participants will receive eye care after the study, if necessary. - Vision-related quality of life: CAT-EyeQ • Health-related measures: - Falling accidents and bone fractures: A shortened version of the *fall and fracture calendar* will be used. Questions are about the number of falls and fractures in the previous 6 months. - Depressive symptomatology will be measured with the Patient Health Questionnaire (PHQ-9) with nine questions corresponding to the Diagnostic Statistical Manual symptoms for major depressive disorder during the past 2 weeks. - Health-related quality of life will be investigated with the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L) which covers the dimensions mobility, self-care, daily activities, pain and discomfort, and anxiety and depression. - Wellbeing: The ICEpop CAPability measure for Older people (ICECAP-O) is a measure of capability in older people for use in economic evaluations. - Health literacy will be measured with the European Health Literacy Survey Questionnaire (HLS-EU-Q16). • Healthcare utilization and cost-effectiveness from a societal perspective: The institute for Medical Technology Assessment (iMTA) Medical Cost Questionnaire (iMCQ) will be used to measure health care utilization at baseline, 6 and 12 months. • Process evaluation: Participants from the intervention group, nurses, professionals from home healthcare services and professionals that participants were refer

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)